[关于贝希特综合征的最新情况]
Theodoros Xenitidis1, Jörg Christoph Henes1
1Medizinische Klinik II (Hämatologie/Onkologie/Klinische Immunologie/Rheumatologie), Vaskulitiszentrum Süd, Universitätsklinikum Tübingen, Tübingen.
Deutsche medizinische Wochenschrift (1946)
|August 23, 2023
概括
贝切特综合征 (BS) 是一种罕见的全身性血管炎,具有多种症状. 最近的进展为眼睛和口腔表现提供了新的治疗方法,但需要进一步开发药物.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 贝切特综合征 (BS) 是一种罕见的系统性血管炎,影响各种血管.
- 其多样化的临床表现带来了诊断和治疗方面的挑战.
- 关键症状包括口腔炎,生殖器炎,皮肤和眼睛的病变.
研究的目的:
- 审查最近在贝赫塞特综合征方面的发现.
- 专注于流行病学,免疫病原生,遗传学,临床发现和治疗.
- 强调诊断和治疗的临床相关性.
主要方法:
- 关于贝希特综合征近期进展的文献综述.
- 对流行病学数据的分析.
- 综合当前对免疫病原发生,遗传学,临床表现和治疗选择的理解.
主要成果:
- 更新的欧洲反风湿联盟 (EULAR) 建议 (2018) 管理指南.
- 阿达利木马布已获批用于眼部干扰 (2016年);阿普雷米拉斯特用于口腔口腔 (2020年).
- 对于新型治疗剂的显著需求仍然存在.
结论:
- 贝切特综合征的治疗需要跨学科的合作.
- 治疗是根据器官参与量身定制的.
- 持续的研究对于开发这种复杂疾病的新疗法至关重要.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Gastritis III: Clinical Manifestations and Management
322
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
322
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
188
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
188
Gastritis-II: Pathophysiology
372
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
372


